Silvia Bio Raises £3 Million Seed Led By Northern Gritstone

Silvia Bio has raised a £3 million seed round led by Northern Gritstone, the investment firm co-founded by universities in northern England, to scale its biomanufacturing platform. Pulse 2.0 reported the deal.

The round is a seed-stage financing. Northern Gritstone sits in the lead position. The stated purpose is straightforward: put the money into scaling the platform Silvia Bio has built.

Who is behind the deal?

Northern Gritstone leads. The firm backs science and technology companies spinning out of the north of England's research base, and it has made early-stage biotech a recurring theme in its portfolio. Leading a £3 million seed checks that pattern.

The exact split of the round — how much came from Northern Gritstone versus any co-investors — wasn't disclosed in the report. The headline figure stands: £3 million, seed stage, Northern Gritstone in the lead.

What does the money buy?

Scale. Silvia Bio's pitch centers on its biomanufacturing platform, and seed capital at this size typically funds exactly that: more capacity, more throughput, and the engineering work to move a platform from proof-of-concept toward commercial volume.

Biomanufacturing — using engineered biological systems to produce materials, ingredients or molecules — has drawn steady seed funding in the UK, and a £3 million round puts Silvia Bio in the typical band for a first institutional raise in the sector.

Why it matters

The deal signals continued appetite among UK deep-tech investors for early-stage biomanufacturing plays, with Northern Gritstone again writing the first significant cheque. The next test for Silvia Bio is converting £3 million in seed capital into a platform that runs at scale.